How Long Does Erosive Esophagitis Take to Heal on PPIs?
At a Glance
Erosive esophagitis often needs an 8-week course of a proton pump inhibitor (PPI), but healing varies with severity. Symptoms can improve before the esophageal lining repairs, and severe disease may require repeat endoscopy, longer treatment, or ongoing acid suppression.
In this answer
3 sections
An initial treatment course for erosive esophagitis using Proton Pump Inhibitors (PPIs) is typically 8 weeks long, but your personal healing timeline depends on the severity of the damage. While heartburn and pain often improve within the first few weeks, the actual repair of the mucosa (the inner lining of your esophagus) takes longer [1][2]. Because of this gap between feeling better and actually being healed, it is crucial to finish your full course of medication exactly as prescribed, without stopping early just because your symptoms improve.
Symptom Relief vs. Tissue Healing
When treating erosive esophagitis, doctors track both how you feel and what the tissue looks like inside your body. It is important to know that symptoms can be misleading: your pain might be gone even if the physical tissue is still damaged, or you might still have symptoms even after the tissue has healed.
- 4 Weeks: At this point, many patients feel significant relief from their symptoms, but approximate study results show that the esophagus has fully healed in less than 80% of people on standard PPI therapy [3][4].
- 8 Weeks: This is a common milestone for reassessment. By the end of an 8-week course, studies show mucosal healing rates generally reach 75% to 95% across all patients with erosive esophagitis [2][4]. However, healing is not guaranteed for everyone, and you may heal sooner or need longer treatment.
How Severity Affects Healing Time
Your healing timeline is heavily influenced by the severity of the damage, which is determined by your endoscopy report using the Los Angeles (LA) Classification System:
- Mild to Moderate (Grades A and B): These grades represent milder erosions and generally respond very well to standard PPI therapy, with high healing rates by the 8-week mark [5]. For these grades, a routine repeat endoscopy is often unnecessary unless your symptoms do not improve.
- Severe (Grades C and D): These grades represent extensive damage where erosions merge together. Healing is more difficult; studies show that after 8 weeks on standard PPIs, the healing rate for Grade C and D is lower, roughly 60% to 70% [6][2][7].
What Happens After 8 Weeks?
If you have severe erosive esophagitis (Grade C or D), your doctor will likely recommend a follow-up endoscopy (a procedure using a camera to look down your throat) around the end of your treatment [6][8]. This is recommended to:
- Confirm healing: Check if the tissue has fully repaired itself.
- Look for complications: Severe inflammation can hide conditions like Barrett’s esophagus (precancerous changes) or strictures (narrowing of the esophagus), which can only be seen clearly once the swelling goes down [6][8].
Long-term management: Severe erosive esophagitis often returns if medication is stopped. Because of this, aggressive, long-term maintenance therapy at the lowest effective dose is usually recommended for Grade C and D [9][10].
If you aren’t healing: If your symptoms persist or your esophagus hasn’t healed after 8 weeks, do not increase or change your medication on your own. Your doctor will first check your medication adherence and meal timing (many PPIs need to be taken 30-60 minutes before a meal). If needed, they may adjust your PPI dose, switch you to a different acid-suppressive agent like a potassium-competitive acid blocker, or evaluate you for other causes of your symptoms [8][11][12].
⚠️ When to Seek Immediate Medical Attention
Do not wait for your 8-week follow-up if you experience any “red flag” symptoms. Contact a doctor or seek urgent care immediately if you have:
Common questions in this guide
How long does erosive esophagitis usually take to heal with a PPI?
Can I feel better even if my erosive esophagitis has not healed?
What should I expect after four or eight weeks of PPI treatment?
How does my Los Angeles grade affect healing time?
Will I need another endoscopy after treatment?
What happens if my erosive esophagitis is not healed after eight weeks?
Which symptoms mean I should seek urgent care?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my exact Los Angeles (LA) grade on my endoscopy report, and were there signs of a hiatal hernia, Barrett's esophagus, or another cause?
- 2.When and how should I take this specific PPI (e.g., before breakfast, twice a day), and what should I do if I miss a dose?
- 3.Should we schedule a follow-up endoscopy after my initial treatment course to confirm the tissue is fully healed?
- 4.What is our plan if I finish this course and still have symptoms, or if the tissue hasn't fully healed?
- 5.Do I need to be on a maintenance dose of this medication long-term to prevent the damage from returning, and how do we step down safely?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
A Double-blind, Randomized, Multicenter Clinical Trial Investigating the Efficacy and Safety of Esomeprazole Single Therapy Versus Mosapride and Esomeprazole Combined Therapy in Patients with Esophageal Reflux Disease.
Lee JY, Kim SK, Cho KB, et al.
Journal of neurogastroenterology and motility 2017; (23(2)):218-228 doi:10.5056/jnm16100.
PMID: 28192647 - 2
Drug treatment strategies for erosive esophagitis in adults: a narrative review.
Shibli F, Mari A, Fass R
Translational gastroenterology and hepatology 2025; (10()):54 doi:10.21037/tgh-24-168.
PMID: 40755734 - 3
A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
Xue Y, Qin X, Zhou L, et al.
Clinical drug investigation 2016; (36(12)):985-992 doi:10.1007/s40261-016-0446-3.
PMID: 27605258 - 4
Induction and maintenance of healing in erosive esophagitis in the United States.
Yadlapati R, Hubscher E, Pelletier C, et al.
Expert review of gastroenterology & hepatology 2022; (16(10)):967-980 doi:10.1080/17474124.2022.2134115.
PMID: 36254610 - 5
A single-center retrospective study on epidemiological and Traditional Chinese Medicine syndrome characteristics of 21010 patients with reflux/heartburn symptoms.
Yanping T, Peicai LI, Xi L, et al.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 2023; (43(3)):574-581 doi:10.19852/j.cnki.jtcm.20220214.001.
PMID: 37147760 - 6
Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan.
Mizuno H, Matsuhashi N, Sakaguchi M, et al.
Journal of clinical biochemistry and nutrition 2015; (57(3)):233-8 doi:10.3164/jcbn.14-144.
PMID: 26566310 - 7
Treatment Strategy for Standard-Dose Proton Pump Inhibitor-Resistant Reflux Esophagitis.
Iwakiri K
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2017; (84(5)):209-214 doi:10.1272/jnms.84.209.
PMID: 29142181 - 8
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R, Gyawali CP, Pandolfino JE,
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(5)):984-994.e1 doi:10.1016/j.cgh.2022.01.025.
PMID: 35123084 - 9
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
Iwakiri K, Kinoshita Y, Habu Y, et al.
Journal of gastroenterology 2016; (51(8)):751-67 doi:10.1007/s00535-016-1227-8.
PMID: 27325300 - 10
The management of gastro-oesophageal reflux disease.
Keung C, Hebbard G
Australian prescriber 2016; (39(1)):6-10 doi:10.18773/austprescr.2016.003.
PMID: 27041798 - 11
The role of vonoprazan in patients with erosive esophagitis.
Zhang M, Xiao Y, Chen M
Therapeutic advances in gastroenterology 2022; (15()):17562848221122623 doi:10.1177/17562848221122623.
PMID: 36117573 - 12
AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.
Patel A, Laine L, Moayyedi P, Wu J
Gastroenterology 2024; (167(6)):1228-1238 doi:10.1053/j.gastro.2024.06.038.
PMID: 39269391
This page is for informational purposes only and does not constitute medical advice. Your gastroenterology clinician should interpret your endoscopy findings, symptoms, and PPI treatment plan.
Get notified when new evidence is published on peptic esophagitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.